LENSAR, Inc. (LNSR) は上場企業です ヘルスケア セクターの Medical - Devices 業界で事業展開. 本社所在地は Orlando, FL, アメリカ. 現CEOは Nicholas T. Curtis.
LNSR を有する IPO日 2020-10-02, 140 名の正社員, に上場 NASDAQ Capital Marke, 時価総額 $75.6M.
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company was incorporated in 2004 and is headquartered in Orlando, Florida.
